The Efficacy of Gefitinib for Non-Adeno Non-Small-Cell Lung Cancer Patients Harboring EGFR Mutations A Pooled Analysis

被引：0
|
作者：
Shukuya, Takehito [1 ]
Takahashi, Toshiaki [1 ]
Ono, Akira [1 ]
Nakamura, Yukiko [1 ]
Tsuya, Asuka [1 ]
Kenmotsu, Hirotsugu [1 ]
Naito, Tateaki [1 ]
Kaira, Kyoichi [1 ]
Murakami, Haruyasu [1 ]
Endo, Masahiro [2 ]
Yamamoto, Nobuyuki [1 ]
机构：
[1] Shizuoka Canc Ctr, Dept Thorac Oncol, Shizuoka, Japan
[2] Shizuoka Canc Ctr, Dept Diagnost Radiol, Shizuoka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [1] Efficacy of gefitinib for non-adenocarcinoma non-small-cell lung cancer patients harboring epidermal growth factor receptor mutations: A pooled analysis of published reports
    Shukuya, Takehito
    Takahashi, Toshiaki
    Kaira, Rieko
    Ono, Akira
    Nakamura, Yukiko
    Tsuya, Asuka
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Kaira, Kyoichi
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Kazuhisa
    Yamamoto, Nobuyuki
    [J]. CANCER SCIENCE, 2011, 102 (05) : 1032 - 1037
  • [2] Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis
    Paz-Ares, Luis
    Soulieres, Denis
    Melezinek, Ivan
    Moecks, Joachim
    Keil, Lorenz
    Mok, Tony
    Rosell, Rafael
    Klughammer, Barbara
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (1-2) : 51 - 69
  • [3] First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations
    Sequist, Lecia V.
    Martins, Renato G.
    Spigel, David
    Grunberg, Steven M.
    Spira, Alexander
    Jaenne, Pasi A.
    Joshi, Victoria A.
    McCollum, David
    Evans, Tracey L.
    Muzikansky, Alona
    Kuhlmann, Georgiana L.
    Han, Moon
    Goldberg, Jonathan S.
    Settleman, Jeffrey
    Iafrate, A. John
    Engelman, Jeffrey A.
    Haber, Daniel A.
    Johnson, Bruce E.
    Lynch, Thomas J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15) : 2442 - 2449
  • [4] Impact of physical size on gefitinib efficacy in patients with non-small cell lung cancer harboring EGFR mutations
    Ichihara, Eiki
    Hotta, Katsuyuki
    Takigawa, Nagio
    Kudo, Kenichiro
    Kato, Yuka
    Hondaa, Yoshihiro
    Hayakawa, Hiromi
    Minami, Daisuke
    Sato, Akiko
    Tabata, Masahiro
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    [J]. LUNG CANCER, 2013, 81 (03) : 435 - 439
  • [5] POOLED ANALYSIS OF CLINICAL OUTCOMES FOR PATIENTS WITH EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCER: AN UPDATE
    Paz-Ares, L.
    Soulieres, D.
    Klughammer, B.
    Bara, I.
    Moecks, J.
    Mok, T. S. K.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 411 - 411
  • [6] Network Meta-Analysis of Erlotinib, Gefitinib, Afatinib and Icotinib in Patients with Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations
    Liang, Wenhua
    Wu, Xuan
    Fang, Wenfeng
    Zhao, Yuanyuan
    Yang, Yunpeng
    Hu, Zhihuang
    Xue, Cong
    Zhang, Jing
    Zhang, Jianwei
    Ma, Yuxiang
    Zhou, Ting
    Yan, Yue
    Hou, Xue
    Qin, Tao
    Dinglin, Xiaoxiao
    Tian, Ying
    Huang, Peiyu
    Huang, Yan
    Zhao, Hongyun
    Zhang, Li
    [J]. PLOS ONE, 2014, 9 (02):
  • [7] Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Mizoguchi, Kosuke
    Nakamura, Yoichi
    Sano, Kazumi
    Sato, Shuntaro
    Ikegami, Yoji
    Motoshima, Kohei
    Takemoto, Shinnosuke
    Ogawara, Daiki
    Senju, Hiroaki
    Sugasaki, Nanae
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Nakatomi, Katsumi
    Fukuda, Minoru
    Izumikawa, Koichi
    Mukae, Hiroshi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (02) : 377 - 382
  • [8] Pharmacokinetic parameters of gefitinib predict efficacy and toxicity in patients with advanced non-small cell lung cancer harboring EGFR mutations
    Kosuke Mizoguchi
    Yoichi Nakamura
    Kazumi Sano
    Shuntaro Sato
    Yoji Ikegami
    Kohei Motoshima
    Shinnosuke Takemoto
    Daiki Ogawara
    Hiroaki Senju
    Nanae Sugasaki
    Takaya Ikeda
    Hiroyuki Yamaguchi
    Katsumi Nakatomi
    Minoru Fukuda
    Koichi Izumikawa
    Hiroshi Mukae
    [J]. Cancer Chemotherapy and Pharmacology, 2016, 78 : 377 - 382
  • [9] Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
    Rossi, Sabrina
    Di Noia, Vincenzo
    Tonetti, Laura
    Strippoli, Antonia
    Basso, Michele
    Schinzari, Giovanni
    Cassano, Alessandra
    Leone, Antonio
    Barone, Carlo
    D'Argento, Ettore
    [J]. FUTURE ONCOLOGY, 2018, 14 (10) : 919 - 926
  • [10] EGFR mutations in non-small-cell lung cancer
    Hung, Jung-Jyh
    Jeng, Wen-Juei
    Hsu, Wen-Hu
    Liu, Jung-Sen
    Wu, Yu-Chung
    [J]. LANCET ONCOLOGY, 2010, 11 (05): : 412 - 413
12345